| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| guaifenesin 90 mg + theophyllin 150 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| guaifenesin 100 mg + theophyllinnatriumglycinat 300 mg eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| guaifenesin 90 mg+ theophyllin, vandfri 150 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| kaliumjodid 130 mg + teofyllin 80 mg vandfri eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| theophyllin 100 mg vandfri tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| guaifenesin 600 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| aminophyllin 25 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| aminophyllin 25 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| aminophyllin 250 mg/10 ml injektionsvæske, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| theophyllin kapsel med modificeret udløsning a 300 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| theophyllin kapsel med modificeret udløsning a 50 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| theophyllin 600 mg vandfri tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing diprophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| aminophyllin tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Aminophylline-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Aminophylline 250 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely aminophylline 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Aminophylline 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| aminophyllin 105 mg/5 ml oral væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing diprophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Diprophylline-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| dyphyllin 300 mg + guaifenesin 300 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| guaifenesin 100 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Siltussin sa 100mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| guaifenesin 1200 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| guaifenesin kapsel med modificeret udløsning a 300 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| guaifenesin kapsel med modificeret udløsning a 600 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| theophyllin med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Mebeverine hydrochloride (substance) |
Is a |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing aminophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| theophyllinnatriumglycinat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| respirationsmuskelrelakserende middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| glatmuskelrelakserende middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| brompheniraminmaleat 2 mg + guaifenesin 200 mg + hydrocodonhydrogentartrat 5 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Ephedrine sulfate 25 mg and guaifenesin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| guaifenesin + oxtriphyllin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing ephedrine and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing diprophylline and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing potassium iodide and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| ephedrinsulfat + hydroxyzinhydrochlorid + theophyllin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing guaifenesin and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| aminophyllinhydrat tablet med modificeret udløsning a 350 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| aminophyllinhydrat tablet med modificeret udløsning a 225 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| aminophyllinhydrat tabletter med modificeret udløsning a 100 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Vardenafil (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Tadalafil (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Montelukast (as montelukast sodium) 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| bivirkning af lægemidler med primær virkning på glatte muskler og skeletmuskler og respirationssystemet |
Causative agent |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
1 |
| Adverse reaction to smooth muscle relaxants |
Causative agent |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to adiphenine |
Causative agent |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| bivirkning af lægemidler med primær virkning på glatte muskler eller skeletmuskler eller respirationssystemet |
Causative agent |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to smooth muscle relaxant NOS |
Causative agent |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing vardenafil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| vardenafil 10 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| vardenafil 5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| vardenafil 20 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Cinnamedrine (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Montelukast sodium 4mg oral granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely theophylline 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| theophyllin kapsel med modificeret udløsning a 65 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| theophyllin kapsel med modificeret udløsning a 130 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| theophyllin kapsel med modificeret udløsning a 260 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| xanthinbronchodilatorer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing dextromethorphan and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| guaifenesin 600 mg med modificeret udløsning/dextromethorphan 30 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| guaifenesin 1200 mg med modificeret udløsning/dextromethorphan 60 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing guaifenesin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing codeine and guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| theophyllin + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing codeine and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing guaifenesin and phenylephrine and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing guaifenesin and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing guaifenesin and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Pseudoephedrine + guaifenesin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing dexbrompheniramine and guaifenesin and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| oxtriphyllin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing 5-lipoxygenase inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Zileuton 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing zileuton (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| guaifenesin 1200 mg + pseudoephedrin 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| guaifenesin 600 mg med modificeret udløsning/pseudoephedrin 60 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing dextromethorphan and guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Adiphenine |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing masoprocol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| allergi over for glatmuskelrelakserende middel |
Causative agent |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
1 |
| Avanafil |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Drotaverine (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Flavoxate (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
FHIR